SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-18
👔
GENELUX Corp
@GNLX_InsiderForm 4 Filing: Yu Yong Acquires (Grant) shares of $GNLX
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
GENELUX Corp
Ticker: $GNLX
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-16
Shares: 119,318
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Yu Yong, holds the title of Chief Scientific Officer at GENELUX Corp.
On 2026-06-16, the insider transacted 119,318 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Yu Yong (Chief Scientific Officer) was granted $0 of $GNLX
Post-Transaction Position: 269,024 shares
SEC Accession No: 0001493152-26-029414 (CIK: 1937482)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.